The Gastrointestinal and Other Cancers Research conducts and supports prevention and early detection research on colorectal, esophageal, liver, pancreatic, and hematolymphoid cancers, as well as new approaches to clinical prevention studies including cancer immunoprevention.
Barrett's Esophagus Translational Research Network (BETRNet)
Multi-disciplinary Research Centers collaborate to enhance understanding of Barrett's esophagus and prevent esophageal adenocarcinoma.
Cancer Prevention Clinical Trials Network (CP-CTNet)
Research Centers develop and conduct early phase clinical trials to assess the preventive potential of agents and interventions of varying classes.
Phase 0/I/II Cancer Prevention Clinical Trials Program (Consortia)
Major medical research centers conduct systematic early clinical development of promising preventive agents.
PREVENT and Consortia Project Results Presented at the AACR Annual Meeting 2019
NCI participated in the American Association for Cancer Research (AACR) Annual Meeting to be held March 29 - April 3, 2019 at Georgia World Congress Center in Atlanta, GA, including the presentation of research results from the latest PREVENT- and Consortia-supported projects.